Works matching Review committees


Results: 5000
    1
    2
    3
    4
    5
    6

    Scientific Review Committees as part of institutional review of human participant research: Initial implementation at institutions with Clinical and Translational Science Awards.

    Published in:
    Journal of Clinical & Translational Science, 2020, v. 4, n. 2, p. 115, doi. 10.1017/cts.2019.439
    By:
    • Selker, Harry P.;
    • Welch, Lisa C.;
    • Patchen-Fowler, Elizabeth;
    • Breeze, Janis L.;
    • Terrin, Norma;
    • Parajulee, Anshu;
    • LeClair, Amy;
    • Naeim, Arash;
    • Marnocha, Rebecca;
    • Morelli Novak, Julie;
    • Caldwell, Christine Sego;
    • Cola, Philip A.;
    • Croker, Jennifer A.;
    • Cifu, David X.;
    • Williams, Kirsten M.;
    • Snyder, Denise C.;
    • Kitterman, Darlene
    Publication type:
    Article
    7
    8
    9
    10

    CTSA Consortium Consensus Scientific Review Committee (SRC) Working Group Report on the SRC Processes.

    Published in:
    CTS: Clinical & Translational Science, 2015, v. 8, n. 6, p. 623, doi. 10.1111/cts.12306
    By:
    • Selker, Harry P.;
    • Buse, John B.;
    • Califf, Robert M.;
    • Carter, Robert;
    • Cooper, Dan M.;
    • Davis, Jonathan;
    • Ford, Daniel E.;
    • Galassetti, Pietro;
    • Guay‐Woodford, Lisa;
    • Huggins, Gordon S.;
    • Kasper, Amanda;
    • Kieburtz, Karl;
    • Kirby, Aaron;
    • Klein, Andreas K.;
    • Kline, Joel;
    • O’ Neill, Robert T.;
    • Rape, Marie;
    • Reichgott, Douglas J.;
    • Rojevsky, Svetlana;
    • Rosenthal, Gary E.
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    36
    37
    38
    39
    40
    41
    42
    44
    45

    Correlation of World Health Organization 2010 Classification for Gastroenteropancreatic Neuroendocrine Neoplasms with the Prognosis of Ovarian Neuroendocrine Neoplasms: Kansai Clinical Oncology Group-Protocol Review Committee/Intergroup Study.

    Published in:
    Neuroendocrinology, 2021, v. 111, n. 4, p. 320, doi. 10.1159/000506743
    By:
    • Kai, Kentaro;
    • Nasu, Kaei;
    • Nishida, Haruto;
    • Daa, Tsutomu;
    • Shikama, Ayumi;
    • Shiozaki, Takaya;
    • Kurakazu, Masamitsu;
    • Yano, Mitsutake;
    • Imamura, Yuko;
    • Tokunaga, Hideki;
    • Tasaki, Kazuto;
    • Iida, Yasushi;
    • Yamada, Yuki;
    • Morisawa, Hiroyuki;
    • Nakagawa, Satoshi;
    • Fujimoto, Etsuko;
    • Tsuruta, Tomohiko;
    • Matsumoto, Harunobu;
    • Arakawa, Atsushi;
    • Nonaka, Michiko
    Publication type:
    Article
    46
    47

    Reply to Trudeau, M.; Fraser, B. The CADTH pCODR Expert Review Committee Process Explained. Comment on "Rayson et al. Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain. Curr. Oncol. 2022, 29 , 9891–9895"

    Published in:
    Current Oncology, 2023, v. 30, n. 5, p. 5050, doi. 10.3390/curroncol30050381
    By:
    • Rayson, Daniel;
    • Gandhi, Sonal;
    • Joy, Anil A.;
    • Brezden-Masley, Christine;
    • Gelmon, Karen A.;
    • Sehdev, Sandeep;
    • Cescon, David;
    • Chia, Stephen
    Publication type:
    Article
    49
    50